Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide aptamer libraries.

Corina Borghouts1, Christian Kunz, Bernd Groner

  • 1Georg-Speyer-Haus, Institute for Biomedical Research, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt am Main, Gemany.

Combinatorial Chemistry & High Throughput Screening
|March 14, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective systematic classification of causes of death in the course of multiple myeloma.

Blood cancer journal·2025
Same author

CD8<sup>+</sup> CD28<sup>-</sup> regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.

Leukemia·2024
Same author

Selective haematological cancer eradication with preserved haematopoiesis.

Nature·2024
Same author

Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis.

Oncology and therapy·2024
Same author

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.

The Lancet. Haematology·2024
Same author

A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same journal

Integrated Multi-Omics Identification of Novel Diagnostic Biomarkers and Immunometabolic Therapeutic Targets in Osteoporosis via Machine Learning.

Combinatorial chemistry & high throughput screening·2026
Same journal

Exploration and Prospects of Core Research Hotspots in the Mechanisms of Traditional Chinese Medicine for Treating Digestive System Malignancies Based on Bibliometrics.

Combinatorial chemistry & high throughput screening·2026
Same journal

Investigating the Potential Pharmacological Mechanisms of Huangqi in Allergic Rhinitis Using Network Pharmacology and Molecular Docking Strategies.

Combinatorial chemistry & high throughput screening·2026
Same journal

DNMT3A-driven Clonal Expansion of Hematopoiesis Influences Autoimmunity Mediated by Distinct Immune Cell Populations: A Mendelian Randomization Study.

Combinatorial chemistry & high throughput screening·2026
Same journal

UPLC-Q-TOF-MS/MS Combined with Network Pharmacology and Molecular Docking Revealed the Mechanism of Zhi Ke He Ji Oral Solution for the Treatment of Pneumonia.

Combinatorial chemistry & high throughput screening·2026
Same journal

Analysis of Chemical Components and Pharmacological Activities of Different Processing Methods in Magnolia denudata Desr. 'Hailuo' Using GC-MS and Network Pharmacology.

Combinatorial chemistry & high throughput screening·2026
See all related articles

Peptide aptamers, which target proteins, offer new drug development possibilities. Researchers explore scaffold proteins and yeast systems for identifying these molecules, enabling new therapeutic strategies.

Area of Science:

  • Biochemistry and Molecular Biology
  • Drug Discovery and Development
  • Protein Engineering

Background:

  • Peptide aptamers are protein-binding molecules that can modulate target protein function.
  • They consist of a variable peptide region (8-20 amino acids) displayed by a scaffold protein.
  • Significant advancements have been made using peptide aptamers in various applications.

Purpose of the Study:

  • To provide an overview of scaffold proteins used for peptide aptamer display.
  • To compare eukaryotic systems (yeast-based) for identifying specific peptide aptamers.
  • To discuss mammalian selection systems for peptide aptamer isolation and their potential in drug development.

Main Methods:

  • Review of scaffold proteins suitable for peptide aptamer presentation.

Related Experiment Videos

  • Comparison of the Gal4 yeast-two-hybrid and LexA interaction trap systems for aptamer screening.
  • Description of high-complexity peptide aptamer library design for yeast systems.
  • Overview of mammalian selection systems utilizing retroviral and lentiviral vectors.

    • Main Results:

    • Identification of various scaffold proteins for peptide aptamer display.
    • Evaluation of yeast-based systems for efficient and specific peptide aptamer selection.
    • Discussion of mammalian systems as alternatives or complements to yeast screens.
    • Demonstration of peptide aptamers as potential inhibitors of signaling pathways.

    Conclusions:

    • Peptide aptamers are versatile tools for targeting protein functions.
    • Yeast-based systems (Gal4, LexA) are effective for identifying specific peptide aptamers.
    • Mammalian systems offer alternative approaches for peptide aptamer isolation.
    • The use of peptide aptamers presents a novel challenge and opportunity for drug development.